Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Absci CorpABSI · Entity 4685 | Chief Legal Officer | March 01, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Absci Corp
Report date March 01, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.01 · Expires 2033-02-28 | Direct | 400,000 |
Reported balance
After 2023-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-01 · Grant · Acquired 400,000 · Balance 400,000 F1: 25% of the shares subject to this option, vest and become exercisable on March 1, 2024, and the remaining 75% of the shares subject to this option, vest and become exercisable in 36 equal monthly installments thereafter, until March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares subject to this option, vest and become exercisable on March 1, 2024, and the remaining 75% of the shares subject to this option, vest and become exercisable in 36 equal monthly installments thereafter, until March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 17:43 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001672688-23-000013 · wf-form4_167788336113762.xml · derivative · entry 1 Korman Sarah · CIK 0001872400 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2033-02-28 F1 · derivative.exercise_date: 25% of the shares subject to this option, vest and become exercisable on March 1, 2024, and the remaining 75% of the shares subject to this option, vest and become exercisable in 36 equal monthly installments thereafter, until March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 21:31 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001628280-22-018416 · wf-form4_165672547265512.xml · derivative · entry 1 Korman Sarah · CIK 0001872400 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-06-30 F1 · derivative.exercise_date: 25% of the shares subject to this option vest and become exercisable on June 14, 2023, and thereafter, the remaining shares subject to this option vest and become exercisable in 36 approximately equal monthly installments until June 14, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:42 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 160,000 | $0.00 Strike: $8.27 | $0.00 |
DisclosureSEC source: 0001628280-22-003611 · wf-form4_164567051607117.xml · derivative · entry 1 Korman Sarah · CIK 0001872400 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2032-02-20 F1 · derivative.exercise_date: 25% of the shares subject to this option vest and become exercisable on February 18, 2023, and thereafter, the remaining shares subject to this option vest and become exercisable in 36 approximately equal monthly installments until February 18, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
| February 09, 2022 Filed Feb 10, 2022 09:01 UTC | Absci Corp ABSI · Entity 4685 | PurchaseCommon Stock | 4,250 | $7.96 | $33,830.00 |
DisclosureSEC source: 0001628280-22-002171 · wf-form4_164450166143986.xml · nonDerivative · entry 1 Korman Sarah · CIK 0001872400 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 F1 · price: Represents the weighted average purchase price of the shares purchased ranging from $7.95 to $8.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:29 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 437,172 | $0.00 Strike: $7.19 | $0.00 |
DisclosureSEC source: 0001628280-22-000726 · wf-form4_164195452449545.xml · derivative · entry 1 Korman Sarah · CIK 0001872400 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,172 Underlying: Common Stock · 437,172 shares Expires 2032-01-06 F1 · derivative.exercise_date: 25% of the shares subject to this option vest and become exercisable on May 27, 2022, and thereafter, the remaining shares subject to this option vest and become exercisable in 36 approximately equal monthly installments until May 27, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 16:34 UTC | Absci Corp ABSI · Entity 4685 | PurchaseCommon Stock | 10,000 | $16.00 | $160,000.00 |
DisclosureSEC source: 0001628280-21-014737 · wf-form4_162750447247728.xml · nonDerivative · entry 1 Korman Sarah · CIK 0001872400 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.